United States · FDA National Drug Code directory
Ibandronate Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55150-191_9e93dc68-5558-4271-9f1f-44f4313babae
- Product NDC
- 55150-191
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Ibandronate Sodium
- Labeler
- Eugia US LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150819
- Source listing expiry
- 20271231
Source-listed ingredients
- IBANDRONATE SODIUM — 3 mg/3mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 CARTON (55150-191-83) / 3 mL in 1 SYRINGE, GLASS · 55150-191-83
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →